Mani Foroohar

Mani Foroohar

Analyst-Equity at Leerink Partners LLC

Finance
Consumer Services

Profile

Dr. Mani Foroohar is a Senior Managing Director of Genetic Medicines at Leerink Partners LLC.
He is also a Senior Research Analyst within the Therapeutics team focusing on Genetic Medicines.
Dr. Foroohar joins Leerink from Aptigon Capital, a Citadel Company, where he most recently was a Therapeutics Analyst focused on U.S.
and EU biotechnology, major pharmaceuticals and specialty pharmaceuticals sectors.
Prior to Aptigon, he was an Analyst at Green Owl Capital Management and an Assistant Vice President of Equity Research at Barclays.
In 2013, he co-founded Cellanyx Diagnostics, a company developing a proprietary live tumor cell, phenotypic platform for precision risk stratification in cancer to inform clinical treatment decision making.
Dr. Foroohar holds an M.D.
from Stanford, where he was a Howard Hughes Medical Institute Research Fellow in the Department of Genetics, M.B.A.
from Columbia, and a B.S.
from UCLA.

Mani Foroohar active positions

CompaniesPositionStart
Analyst-Equity 01/05/2018
All active positions of Mani Foroohar

Former positions of Mani Foroohar

CompaniesPositionEnd
Analyst-Equity 01/12/2014
Analyst-Equity -
See the detail of Mani Foroohar's experience

Training of Mani Foroohar

University of California, Los Angeles Undergraduate Degree
Stanford University School of Medicine Doctorate Degree
Columbia Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mani Foroohar's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies3

Finance

Finance

Finance

See company connections